Home LiteratureArticle Details
PMID: 22300858 Published · ppublish English Letter Comment

A STEPP too far for FLEX?

The Lancet. Oncology ·Vol. 13 ·No. 2 ·2012-02-00 ·Pages e51; author reply e51

Bergot E, Creveuil C, Zalcman G

Abstract

暂无摘要

MeSH Terms
Antineoplastic Combined Chemotherapy Protocols/therapeutic use Biomarkers, Tumor/metabolism Carcinoma, Non-Small-Cell Lung/drug therapy ErbB Receptors/metabolism Female Humans Lung Neoplasms/drug therapy Male
Chemicals
Biomarkers, Tumor ErbB Receptors
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Bergot Emmanuel
Creveuil Christian
Zalcman Gérard
Article Info
Journal
The Lancet. Oncology
Abbr.
Lancet Oncol
ISSN
1474-5488
DOI
10.1016/S1470-2045(12)70056-6
Published
2012-02-00
Pages
e51; author reply e51
Language
English
Region
England
NLM ID
100957246
Subset
IM
Corrections
CommentOn
PMID: 22056021
External Links
PubMed source DOI: 10.1016/S1470-2045(12)70056-6 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2